Recent studies have shown that c-Met is a putative stem/progenitor cell marker in colorectal cancer, glioblastoma, and breast cancer (Di Renzo et al., 1991; Li et al., 2011; Baccelli et al., 2013; Lin et al., 2019). This evidence concerns the gene MET and breast cancer.